<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H63D154534CE64EEEA465BBF11C97E465" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 4501 IH: Combating the Opioid Epidemic Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2017-11-30</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 4501</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20171130">November 30, 2017</action-date><action-desc><sponsor name-id="L000565">Mr. Loebsack</sponsor> (for himself, <cosponsor name-id="S001170">Ms. Shea-Porter</cosponsor>, <cosponsor name-id="N000179">Mrs. Napolitano</cosponsor>, and <cosponsor name-id="K000382">Ms. Kuster of New Hampshire</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To increase funding for the State response to the opioid misuse crisis and to provide funding for
			 research on addiction and pain related to the substance misuse crisis.</official-title></form>
	<legis-body id="H7D404F379F8B4D82B50F7EDFAE698B4E" style="OLC">
 <section id="HCCAAB05C697E4A0791706055454EA144" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Combating the Opioid Epidemic Act</short-title></quote>.</text> </section><section id="HFE695C6A32EF48D399E26B8F50D224D1"><enum>2.</enum><header>Additional funding for the State response</header> <subsection id="H5C40971293C54BD98F0900BD22C4C4C1"><enum>(a)</enum><header>Funding</header><text display-inline="yes-display-inline">Section 1003 of the 21st Century Cures Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290ee-3">42 U.S.C. 290ee–3</external-xref> note) is amended—</text>
 <paragraph id="H8A8F4AE5AE53461FAE012B65155A18B5"><enum>(1)</enum><text display-inline="yes-display-inline">in subsection (a), by striking <quote>under subsection (b)</quote> and inserting <quote>under subsection (b)(3) and the appropriations under subsection (b)(4)</quote>;</text> </paragraph><paragraph id="H22ACBB341681402CA9FA4A9FF6C9B686"><enum>(2)</enum><text display-inline="yes-display-inline">in subsection (b), by adding at the end the following:</text>
					<quoted-block display-inline="no-display-inline" id="H291DEFF73941476FA4B432315D43EF74" style="OLC">
 <paragraph id="HC8112939AADE46DEABF6EA0E0C08DB14"><enum>(4)</enum><header>Additional appropriations</header><text>In addition to the amounts transferred to the Account under paragraph (2)(A), there are authorized to be appropriated, and there are appropriated, to the Secretary, out of monies in the Treasury not otherwise obligated, $4,474,800,000 for each of fiscal years 2018 through 2027, to carry out the grant program described in subsection (c). Such funds shall remain available until expended.</text></paragraph><after-quoted-block>; and</after-quoted-block></quoted-block>
 </paragraph><paragraph id="HDA7E6D906F0E443E949298B90F06E268"><enum>(3)</enum><text>by striking subsection (f).</text> </paragraph></subsection><subsection id="H58C54C4538A64384A10AE979B0328343"><enum>(b)</enum><header>Activities</header><text>Section 1003(c)(1) of the 21st Century Cures Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290ee-3">42 U.S.C. 290ee–3</external-xref> note) is amended—</text>
 <paragraph id="HD0E80F44308F4271B4943D2B00ADAE68"><enum>(1)</enum><text>by redesignating subparagraph (E) as subparagraph (G); and</text> </paragraph><paragraph id="H7C34C4EAA91040EB8FBF5C1FA83A030C"><enum>(2)</enum><text>by inserting after subparagraph (D) the following:</text>
					<quoted-block display-inline="no-display-inline" id="H82DE231A879D4AD3BDBC6721708550DF" style="OLC">
 <subparagraph id="HCD9B2F461FFA47BB987AF1341C9CFCCA"><enum>(E)</enum><text>Detection, surveillance, and treatment of co-occurring infections associated with the opioid epidemic, including hepatitis C and HIV.</text>
 </subparagraph><subparagraph id="H4949C67C994F4B9BABA1D16E4EAB7B3E"><enum>(F)</enum><text>Surveillance, data collection, and timely and consistent reporting on the number of opioid overdose deaths, including the incidence and prevalence of co-occurring infections and toxicology reporting on the number of deaths where fentanyl or other illicit opioid analogs were detected.</text></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</paragraph></subsection></section><section id="H8B6DC1DB99284B1390D1668AD6A4A96B"><enum>3.</enum><header>Grants for research on addiction and pain</header>
 <subsection id="HC943EE9040B146C3BDC8AA39473387CE"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services (referred to in this section as the <quote>Secretary</quote>) shall use any funds appropriated under subsection (b) to award grants for the purpose of conducting research on addiction and pain related to substance misuse. The Secretary, acting through the Director of the National Institutes of Health, shall determine the amount of each grant awarded under this section.</text>
 </subsection><subsection id="HAF73FD2ACC374218A8D8BB581AD1DCAD"><enum>(b)</enum><header>Appropriations</header><text>There are authorized to be appropriated, and there are appropriated, to the Secretary, out of monies in the Treasury not otherwise obligated, $50,400,000 for each of fiscal years 2018 through 2022, to carry out the grant program described in subsection (a). Such funds shall remain available until expended.</text>
			</subsection></section></legis-body></bill>


